Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucienne Chatenoud

Showing results (21-30 of 137) with videos related to

Pageof 14
Sort By:
Medecine Sciences : M/S|February 13, 2007
[One step towards restoration of self-tolerance in human autoimmune diseases]Lucienne Chatenoud
Nature Reviews. Endocrinology|February 23, 2010
Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?Lucienne Chatenoud
Transplant International : Official Journal of the European Society for Organ Transplantation|June 25, 2008
The long and winding road towards induction of allograft tolerance in the clinicLucienne Chatenoud
Nature Reviews. Immunology|February 4, 2003
CD3-specific antibody-induced active tolerance: from bench to bedsideLucienne Chatenoud
Nature Reviews. Endocrinology|September 1, 2011
Diabetes: type 1 diabetes mellitus--a door opening to a real therapy?Lucienne Chatenoud
The Review of Diabetic Studies : RDS|June 28, 2013
CD3 monoclonal antibodies: a first step towards operational immune tolerance in the clinicLucienne Chatenoud, Herman Waldmann
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2015
Autoimmune Diabetes: An Overview of Experimental Models and Novel TherapeuticsSylvaine You, Lucienne Chatenoud
The Journal of Clinical Investigation|December 5, 2006
Proinsulin: a unique autoantigen triggering autoimmune diabetesSylvaine You, Lucienne Chatenoud
Current Opinion in Organ Transplantation|October 1, 2010
New generation CD3 monoclonal antibodies: are we ready to have them back in clinical transplantation?Sylvaine You, Lucienne Chatenoud
Current Opinion in Organ Transplantation|December 2, 2017
Revisiting the phenotypic and genetic profiling of anergic T cells mediating long-term transplant toleranceSylvaine You, Lucienne Chatenoud
Pageof 14

Showing results (21-30 of 137) with videos related to

Sort By:
Pageof 14
Medecine Sciences : M/S|February 13, 2007
[One step towards restoration of self-tolerance in human autoimmune diseases]Lucienne Chatenoud
Nature Reviews. Endocrinology|February 23, 2010
Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?Lucienne Chatenoud
Transplant International : Official Journal of the European Society for Organ Transplantation|June 25, 2008
The long and winding road towards induction of allograft tolerance in the clinicLucienne Chatenoud
Nature Reviews. Immunology|February 4, 2003
CD3-specific antibody-induced active tolerance: from bench to bedsideLucienne Chatenoud
Nature Reviews. Endocrinology|September 1, 2011
Diabetes: type 1 diabetes mellitus--a door opening to a real therapy?Lucienne Chatenoud
The Review of Diabetic Studies : RDS|June 28, 2013
CD3 monoclonal antibodies: a first step towards operational immune tolerance in the clinicLucienne Chatenoud, Herman Waldmann
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2015
Autoimmune Diabetes: An Overview of Experimental Models and Novel TherapeuticsSylvaine You, Lucienne Chatenoud
The Journal of Clinical Investigation|December 5, 2006
Proinsulin: a unique autoantigen triggering autoimmune diabetesSylvaine You, Lucienne Chatenoud
Current Opinion in Organ Transplantation|October 1, 2010
New generation CD3 monoclonal antibodies: are we ready to have them back in clinical transplantation?Sylvaine You, Lucienne Chatenoud
Current Opinion in Organ Transplantation|December 2, 2017
Revisiting the phenotypic and genetic profiling of anergic T cells mediating long-term transplant toleranceSylvaine You, Lucienne Chatenoud
Pageof 14